What might be the consequences of designing your baby? Hein Kaiser | Caxton Network News | January 27, 2026

https://geneticliteracyproject.org/2026/01/27/what-might-be-the-consequences-of-designing-your-baby/

Gene therapy can restore hearing in some people born with congenital deafness Maoli Duan | January 27, 2026

https://geneticliteracyproject.org/2026/01/27/gene-therapy-can-restore-hearing-in-some-people-born-with-congenital-deafness/?mc_cid=e19d405dce&mc_eid=b73600b7ac

18th Annual Hematologic Malignancies Demystified conference January 31, 2026 | February 7, 2026

January 31, 2026 | February 7, 2026 https://www.medscapelive.org/website/83337/?utm_campaign=lbu_hmd2026_virtual_01-26_cmece&utm_source=prop&utm_theraputic_area=1600&utm_medium=em&utm_content=int

Could chronic diarrhea actually signal severe fecal impaction (Medscape AI)

https://www.medscape.com/ai-search?query=Could%20chronic%20diarrhea%20actually%20signal%20severe%20fecal%20impaction&ecd=wnl_tp10_daily_260122_MSCPEDIT_etid8045867&uac=148436CN&impID=8045867 Chronic or recurrent loose stools in a patient with signs of constipation may paradoxically represent overflow around an unrecognized fecal mass rather than true secretory diarrhea.

The patient impact of 11 years of ocrelizumab treatment in multiple sclerosis: long-term data from the Phase III OPERA and ORATORIO studies

The patient impact of 11 years of ocrelizumab treatment in multiple sclerosis: long-term data from the Phase III OPERA and ORATORIO studies Early and sustained treatment of patients with MS with a high efficacy therapy delays disability progression and the time to reaching key long-term disability milestones. OCR has a robust long-term safety and efficacy experience across the MS spectrum. Results for OCR over eleven years are reported for 48-week CDP and other measures of progression (including the rate of repeated 48-week CDP, and the time to requiring walking aid or wheelchair) during OPERA I/II (NCT01247324/NCT01412333), ORATORIO (NCT01194570) and their open-label extensions. https://medically.roche.com/global/en/medical-material.7539ff6d-3fbb-422c-bd07-6b2f2616a529.qr.html?cid=slpsectrims20242409xxnvspht

The Patient Impact of 10 Years of Ocrelizumab Treatment in Multiple Sclerosis: Long-Term Data from the Phase III OPERA and ORATORIO Studie

https://medically.roche.com/content/dam/pdmahub/restricted/neurology/ectrims-2023/ECTRIMS-2023-poster-weber-the-patient-impact-of-10-years-of-ocrelizumab.pdf

Does vitamin D supplementation meaningfully reduce mortality or length of stay in sepsis (Medscape AI)

https://www.medscape.com/ai-search?query=Does%20vitamin%20D%20supplementation%20meaningfully%20reduce%20mortality%20or%20length%20of%20stay%20in%20sepsis&%20&ecd=wnl_tp10_daily_260123_MSCPEDIT_etid8049873&uac=148436CN&impID=8049873 In sepsis, direct interventional data on vitamin D supplementation and its impact on mortality or hospital length of stay are lacking. However, observational and meta-analytic data link vitamin D deficiency with worse outcomes in critically ill patients, suggesting a potential but unproven role for supplementation.